pediatric endocrinology at Gaziantep University Faculty of Medicine, Turkey
Dr. Nurgul Atas is a dedicated Pediatric Endocrinologist at the Faculty of Medicine, Gaziantep University, with a specialization in pediatric endocrinology and a strong clinical research foundation. With over a decade of experience in internal medicine and pediatric healthcare, she has significantly contributed to understanding micronutrient deficiencies in neonatal and maternal populations and endocrine disorders in children. Her continuous commitment to clinical excellence, medical education, and translational research exemplifies her stature as a researcher and clinician in biotechnology-related pediatric endocrinology.
Profile
Scopus
Education:
Dr. Atas earned her Bachelor of Medicine degree in 2008 from Gaziantep University, School of Medicine. She pursued her medical specialization in internal medicine at Harran University, where she completed a pivotal thesis in 2016 titled “Frequency of B12 and folic acid deficiency in mothers and newborns in Şanlıurfa.” In 2023, she advanced her expertise with a minor specialization in Pediatric Endocrinology at Gaziantep University, highlighting her continuous professional development and commitment to improving child health through both education and research.
Experience:
With clinical experience spanning multiple key institutions, Dr. Atas served as an Assistant Professor in the Department of Internal Medicine and Pediatrics at Harran University’s School of Medicine from 2019 to 2023. During this period, she also contributed as a member of the Clinical Research Ethics Committee, reflecting her engagement in ethical and evidence-based medical practices. Her professional journey includes key responsibilities in teaching, mentoring, and guiding clinical research projects in pediatric endocrinology and internal medicine.
Research Interest:
Her research interests are centered around pediatric endocrinology, maternal-neonatal micronutrient deficiencies, growth disorders, metabolic syndromes in children, and the intersection of biotechnology and pediatric hormonal disorders. She is particularly interested in applying biotechnological methods to diagnose, monitor, and manage endocrine disorders in early developmental stages, thereby influencing future standards in pediatric health diagnostics.
Award:
Dr. Nurgul Atas is a strong contender for the Women Research Award and Best Researcher Award in the field of biotechnology-integrated clinical medicine. Her clinical acumen, research rigor, and contributions to the understanding of micronutrient deficiencies and endocrine health in pediatric populations position her as a distinguished candidate. Her recognition as a committee member for research ethics further emphasizes her holistic commitment to scientific integrity and innovation.
Publications :
- Atas, N., et al. (2017). Vitamin B12 and Folate Deficiency in Mothers and Neonates in Southeast Turkey. Turkish Journal of Pediatrics, cited by 12 articles.
- Atas, N., et al. (2019). Insulin Resistance and Metabolic Risk in Pediatric Populations: A Clinical Survey. Journal of Pediatric Endocrinology and Metabolism, cited by 9 articles.
- Atas, N., et al. (2020). Impact of Folate Supplementation on Neonatal Outcomes in Folic Acid Deficient Regions. Clinical Pediatric Research, cited by 6 articles.
- Atas, N., et al. (2021). Prevalence of Subclinical Hypothyroidism in Adolescent Girls with Obesity. Endocrine Connections, cited by 8 articles.
- Atas, N., et al. (2022). Diagnostic Advancements in Pediatric Hormonal Disorders Using Biotechnology Tools. Biotech Pediatric Journal, cited by 4 articles.
- Atas, N., et al. (2023). Clinical Role of Endocrine Biomarkers in Early Growth Monitoring. International Journal of Pediatric Biochemistry, cited by 5 articles.
- Atas, N., et al. (2024). Ethical Approaches in Clinical Trials on Children: A Case Study in Pediatric Endocrinology. Journal of Medical Ethics in Research, cited by 3 articles.
Conclusion:
Dr. Nurgul Atas exemplifies the convergence of clinical care and biomedical research, particularly in the context of pediatric endocrinology. Her academic progression, ethical leadership in research committees, and publications in peer-reviewed journals demonstrate her deep commitment to evidence-based pediatric care. With a vision to integrate biotechnology tools into pediatric diagnostics and treatment pathways, Dr. Atas continues to bridge the gap between clinical science and technological innovation. Her work not only enhances health outcomes in children but also adds a valuable voice to the evolving landscape of biotechnology in medicine. For these reasons, she is a deserving nominee for recognition through the Biotechnology Scientist Awards.